Medicamen Biotech Limited (NSE:MEDICAMEQ)
India · Delayed Price · Currency is INR 245.00
-0.65 (-0.26%)
Jun 8, 2026, 11:49 AM IST
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.12 billion as of June 5, 2026. Its market cap has decreased by -45.67% in one year.
Market Cap
3.12B
Enterprise Value
3.28B
Revenue
2.01B
Ranking
n/a
PE Ratio
32.35
Stock Price
245.00
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.12B, an increase of 2,774.85%. That is a compound annual growth rate of 16.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 3.12B | -32.43% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 13.66B |
| Ind-Swift Laboratories | 13.59B |
| Sigachi Industries | 8.19B |
| Valiant Laboratories | 4.05B |
| Bafna Pharmaceuticals | 3.79B |
| Nectar Lifesciences | 2.33B |
| Brooks Laboratories | 1.91B |
| Alpa Laboratories | 1.45B |